Fragmento

Branco, et al. The aim of this study was to evaluate the outcome of patients who performed orthotopic liver transplantation (LT) as treatment for hepatocellular carcinoma (HCC), with percutaneous ethanol injection (PEI) while on the waiting list, verifying the effectiveness of this treatment in producing tumor necrosis and avoiding dropout and identifying treatment-related complications. The authors analyze the medical records of 97 patients on the waiting list for LT. Sixty-two (56.3%) patients had been treated with PEI (group 1); 35 (31.8%) had not received any anti-tumor therapy before LT (group 2). The authors found that complete necrosis of the tumor was observed in 38/59 (64.3%) patients. Also the presence of additional nodules in the explant and the diameter of the main tumor of group 1 was significantly lower than in group 2 (p = 0.002). The authors concluded that percutaneous treatment of HCC with PEI is a safe and effective method before the LT.

Palabras clave:

2009-11-27   |   700 visitas   |   Evalua este artículo 0 valoraciones

Vol. 8 Núm.3. Julio-Septiembre 2009 Pags. 175-176 Ann Hepatol 2009; 8(3)